Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Adaptin Bio (APTN) Long-Term Debt Issuances (2023 - 2024)

Adaptin Bio recorded quarterly Long-Term Debt Issuances of $25192.0 in Q3 2024, down 88.68% quarter-over-quarter from $222542.0 in Q2 2024.

Adaptin Bio's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $25192.0 for Q3 2024.

  • In Q3 2024, Long-Term Debt Issuances changed N/A year-over-year to $25192.0; the TTM figure through Dec 2024 stood at $337734.0 (changed N/A YoY), while the FY2024 annual figure was $1.0 million, up 1135.86% from the prior year.
  • Long-Term Debt Issuances came in at $25192.0 for Q3 2024 at Adaptin Bio, down from $222542.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $222542.0 in Q2 2024 to a low of $25192.0 in Q3 2024.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 25,192.00
Sep 30, 2024 25,192.00
Jun 30, 2024 222,542.00
Jun 30, 2024 222,542.00
Mar 31, 2024 90,000.00
Mar 31, 2024 90,000.00
Dec 31, 2023 58,347.00
Dec 31, 2023 58,347.00